Announcement on Voluntary Disclosure of Clinical Data and Latest Progress of ZG006 Presented at the 2025 European Society for Medical Oncology Asian Annual Meeting (ESMOAsia)

About this update from Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A

Announcement on Voluntary Disclosure of Clinical Data and Latest Progress of ZG006 Presented at the 2025 European Society for Medical Oncology Asian Annual Meeting (ESMOAsia) The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A